Title | Type | ![]() |
H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Neuropharmacology | journal | 1.531 Q1 | 65 | 85 | 317 | 10853 | 1489 | 290 | 4.76 | 127.68 | ![]() |
2 | Clinical Cancer Drugs | journal | 1.287 Q1 | 4 | 0 | 1 | 0 | 3 | 1 | 0.00 | 0.00 | ![]() |
3 | Current Medicinal Chemistry | journal | 0.903 Q1 | 167 | 432 | 881 | 49124 | 3140 | 830 | 3.76 | 113.71 | ![]() |
4 | Current Cancer Drug Targets | journal | 0.893 Q1 | 89 | 81 | 230 | 6341 | 623 | 219 | 2.75 | 78.28 | ![]() |
5 | CNS and Neurological Disorders - Drug Targets | journal | 0.832 Q2 | 81 | 75 | 352 | 5633 | 981 | 311 | 3.56 | 75.11 | ![]() |
6 | Current Topics in Medicinal Chemistry | journal | 0.788 Q2 | 111 | 231 | 803 | 22201 | 2471 | 693 | 3.23 | 96.11 | ![]() |
7 | Current Gene Therapy | journal | 0.782 Q2 | 68 | 37 | 131 | 2569 | 260 | 118 | 2.24 | 69.43 | ![]() |
8 | Current Drug Targets | journal | 0.741 Q2 | 96 | 139 | 546 | 15568 | 1410 | 505 | 2.71 | 112.00 | ![]() |
9 | Current Drug Metabolism | journal | 0.650 Q2 | 102 | 122 | 305 | 9571 | 843 | 281 | 2.84 | 78.45 | ![]() |
10 | Current Molecular Pharmacology | journal | 0.629 Q2 | 37 | 28 | 97 | 2442 | 221 | 86 | 2.98 | 87.21 | ![]() |
11 | Current Pharmaceutical Design | journal | 0.606 Q2 | 149 | 450 | 1769 | 45559 | 4096 | 1640 | 2.26 | 101.24 | ![]() |
12 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.603 Q2 | 40 | 29 | 95 | 2940 | 241 | 94 | 2.63 | 101.38 | ![]() |
13 | Current Vascular Pharmacology | journal | 0.559 Q3 | 57 | 51 | 257 | 3613 | 443 | 216 | 2.14 | 70.84 | ![]() |
14 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.543 Q3 | 90 | 0 | 420 | 0 | 1000 | 408 | 2.37 | 0.00 | ![]() |
15 | Mini-Reviews in Medicinal Chemistry | journal | 0.500 Q2 | 85 | 319 | 593 | 21790 | 1365 | 559 | 2.27 | 68.31 | ![]() |
16 | Current Pharmaceutical Biotechnology | journal | 0.497 Q2 | 81 | 135 | 390 | 8715 | 766 | 357 | 2.20 | 64.56 | ![]() |
17 | Current Clinical Pharmacology | journal | 0.475 Q2 | 37 | 27 | 102 | 1372 | 175 | 95 | 1.86 | 50.81 | ![]() |
18 | Current Radiopharmaceuticals | journal | 0.447 Q3 | 24 | 26 | 91 | 1385 | 161 | 83 | 2.16 | 53.27 | ![]() |
19 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.436 Q3 | 24 | 17 | 44 | 1636 | 101 | 43 | 2.03 | 96.24 | ![]() |
20 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.399 Q3 | 21 | 0 | 26 | 0 | 41 | 24 | 0.86 | 0.00 | ![]() |
21 | Reviews on Recent Clinical Trials | journal | 0.361 Q3 | 31 | 43 | 131 | 1922 | 130 | 120 | 1.20 | 44.70 | ![]() |
22 | Current Drug Delivery | journal | 0.359 Q2 | 58 | 84 | 401 | 5455 | 646 | 388 | 1.52 | 64.94 | ![]() |
23 | Medicinal Chemistry | journal | 0.344 Q3 | 42 | 82 | 258 | 4430 | 487 | 252 | 2.32 | 54.02 | ![]() |
24 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.330 Q3 | 39 | 27 | 71 | 2335 | 104 | 66 | 1.47 | 86.48 | ![]() |
25 | Current Drug Safety | journal | 0.304 Q3 | 33 | 45 | 124 | 1237 | 144 | 121 | 1.31 | 27.49 | ![]() |
26 | Current Drug Discovery Technologies | journal | 0.297 Q3 | 40 | 50 | 77 | 2745 | 104 | 75 | 1.40 | 54.90 | ![]() |
27 | Combinatorial Chemistry and High Throughput Screening | journal | 0.296 Q3 | 62 | 82 | 285 | 3127 | 370 | 259 | 1.31 | 38.13 | ![]() |
28 | Current Pharmaceutical Analysis | journal | 0.286 Q2 | 23 | 89 | 217 | 2773 | 184 | 214 | 0.89 | 31.16 | ![]() |
29 | Recent Patents on Anti-Infective Drug Discovery | journal | 0.278 Q3 | 29 | 8 | 49 | 404 | 54 | 44 | 1.09 | 50.50 | ![]() |
30 | Recent Patents on Drug Delivery and Formulation | journal | 0.277 Q2 | 32 | 24 | 60 | 1942 | 74 | 56 | 1.17 | 80.92 | ![]() |
31 | Infectious Disorders - Drug Targets | journal | 0.267 Q3 | 51 | 54 | 88 | 2210 | 88 | 82 | 1.05 | 40.93 | ![]() |
32 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.251 Q3 | 21 | 12 | 52 | 490 | 49 | 49 | 1.04 | 40.83 | ![]() |
33 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.246 Q3 | 37 | 17 | 58 | 665 | 63 | 51 | 1.52 | 39.12 | ![]() |
34 | Current Nanoscience | journal | 0.246 Q2 | 40 | 72 | 242 | 4405 | 386 | 231 | 1.93 | 61.18 | ![]() |
35 | Letters in Drug Design and Discovery | journal | 0.240 Q2 | 30 | 115 | 444 | 5034 | 461 | 436 | 1.17 | 43.77 | ![]() |
36 | Current Bioactive Compounds | journal | 0.236 Q2 | 22 | 51 | 139 | 2498 | 127 | 130 | 1.08 | 48.98 | ![]() |
37 | Drug Metabolism Letters | journal | 0.233 Q2 | 25 | 14 | 77 | 675 | 80 | 68 | 1.21 | 48.21 | ![]() |
38 | Open Medicinal Chemistry Journal![]() | journal | 0.220 Q3 | 16 | 6 | 32 | 245 | 44 | 29 | 1.52 | 40.83 | ![]() |
39 | Current Computer-Aided Drug Design | journal | 0.216 Q4 | 27 | 40 | 106 | 1649 | 84 | 92 | 0.91 | 41.23 | ![]() |
40 | Current Enzyme Inhibition | journal | 0.204 Q4 | 16 | 15 | 63 | 394 | 38 | 59 | 0.66 | 26.27 | ![]() |
41 | Current Drug Therapy | journal | 0.160 Q3 | 16 | 21 | 44 | 1450 | 27 | 41 | 0.50 | 69.05 | ![]() |
42 | Recent Patents on CNS Drug Discovery | journal | 0.156 Q4 | 32 | 0 | 18 | 0 | 10 | 17 | 0.00 | 0.00 | ![]() |
43 | Anti-Infective Agents | journal | 0.155 Q4 | 22 | 17 | 56 | 628 | 30 | 53 | 0.43 | 36.94 | ![]() |
44 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.131 Q4 | 16 | 0 | 43 | 0 | 15 | 40 | 0.43 | 0.00 | ![]() |
45 | Current Pharmacogenomics and Personalized Medicine | journal | 0.116 Q4 | 18 | 0 | 51 | 0 | 14 | 45 | 0.33 | 0.00 | ![]() |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2020. Data Source: Scopus®